Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer
Sabrina Piedimonte, Rachel Kim, Marcus Q. Bernardini, Eshetu G. Atenafu, Mitchell Clark, Stéphanie Lheureux, Taymaa May
Topics & Concepts
MedicineInternal medicineOvarian cancerBevacizumabProgression-free survivalChemotherapyStage (stratigraphy)Serous fluidCohortOncologyRetrospective cohort studyCancerGastroenterologyPaleontologyBiologyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyIntraperitoneal and Appendiceal Malignancies